Brain Flexibility Is Linked to Hand Coordination During Aging

These findings underscore an age-related shift in the neural dynamics underpinning motor adaptability with aging, pointing to increased BOLD variability modulation as a potential marker of compensatory reorganization in late adulthood.”

Coordinating both hands is something most people take for granted. Everyday activities such as buttoning a shirt, preparing a meal, driving, or using a knife and fork all depend on the brain’s ability to precisely control movements on both sides of the body. As people age, however, these tasks often become more difficult, especially when they require both hands to perform different movements at the same time.

A research paper published in Volume 18 of Aging titled “Age-specific relationship between the modulation of brain dynamics in response to task demands and bimanual performance,” investigated how aging affects the brain’s ability to adapt to increasingly complex hand-coordination tasks. The study was led by first author Sara Magalhães Ferreira from Hasselt University, with corresponding author Koen Cuypers from Hasselt University and KU Leuven.

Looking Beyond Brain Activation

For many years, scientists studying healthy aging have focused primarily on which brain regions become more or less active during movement. However, brain activity is not static. Even while performing the same task, activity naturally fluctuates from moment to moment.

These fluctuations, known as Blood Oxygen Level-Dependent (BOLD) variability, may provide important information about how flexibly the brain adapts to changing demands. Rather than measuring average brain activity alone, BOLD variability reflects the dynamic changes in neural activity over time and has emerged as a potential indicator of neural adaptability and efficiency.

Although previous studies have linked BOLD variability to cognitive aging, its role in complex motor functions such as coordinating both hands had remained largely unexplored.

Testing How the Aging Brain Responds to Increasing Motor Demands

To investigate this question, the researchers recruited 22 younger adults and 23 older adults, who performed a series of increasingly challenging bimanual tracking tasks while undergoing functional magnetic resonance imaging (fMRI).

The tasks required participants to coordinate both hands under three levels of difficulty. While some tasks involved moving both hands together in relatively simple patterns, others required different movement speeds and timing between the hands, placing greater demands on motor control and executive function.

As expected, older adults performed less accurately than younger adults, particularly during the most complex coordination task.

The Brain Responded Differently With Age

Rather than simply comparing overall brain activity, the researchers examined how BOLD variability changed as task difficulty increased.

Older adults showed greater BOLD variability in a cerebellar region and greater modulation of BOLD variability across several sensorimotor and cerebellar regions as task demands increased. These findings suggest that the aging brain adjusts its neural activity differently when faced with more challenging movements.

Importantly, these findings suggest that the changes reflected different strategies for adapting to increasing motor demands rather than simply indicating reduced brain function.

Different Brain Strategies Predicted Better Performance

One of the study’s most interesting findings was that the relationship between brain dynamics and motor performance differed between younger and older adults.

Among younger adults, smaller changes in BOLD variability within several sensorimotor and visuospatial brain regions were associated with better task performance. This suggests that younger brains may already operate efficiently and require relatively little adjustment as task difficulty increases.

In contrast, older adults who showed greater modulation of BOLD variability in regions of the parietal cortex generally performed better on the coordination tasks. These brain areas help integrate sensory information, guide movement, and support attention during complex motor activities.

Across both age groups, greater modulation in the middle occipital gyrus—a region involved in visual processing—was associated with better performance, whereas greater modulation in the cerebellar Crus I was linked to poorer performance. These findings suggest that the contribution of individual brain regions to successful movement changes with age.

How the Aging Brain May Adapt

Although the study was not designed to determine the precise biological mechanisms behind these findings, the results support the idea that the aging brain can reorganize its activity to compensate for age-related changes.

Rather than relying on the same neural strategies used by younger adults, older individuals may recruit additional brain networks and dynamically adjust neural activity as task demands increase. This flexible reorganization may help preserve motor function despite the structural and physiological changes that naturally occur with aging.

The findings are consistent with theories suggesting that healthy aging involves both gradual neural decline and compensatory adaptations that help maintain everyday function.

What Makes This Study Different?

Most previous neuroimaging studies of aging have focused on average brain activation. In contrast, this study examined how fluctuations in brain activity change as movement tasks become more demanding.

It is also among the first studies to investigate BOLD variability during complex bimanual coordination rather than cognitive tasks alone. By combining advanced functional MRI analyses with increasingly difficult motor challenges, the researchers were able to identify age-specific patterns of neural adaptability that traditional measures of brain activation may overlook.

Looking Ahead

The authors conclude that aging is associated with important changes in how the brain dynamically responds to increasing motor demands. Rather than reflecting simple decline, greater modulation of brain activity in certain regions may represent a compensatory strategy that helps older adults maintain coordinated movement.

Although larger studies will be needed to confirm these findings, the results suggest that measuring BOLD variability may provide new insights into healthy brain aging and motor adaptability. As researchers continue to investigate the neural mechanisms underlying movement, these findings may help guide future strategies aimed at preserving coordination, independence, and quality of life throughout aging.

Click here to read the full research paper published in Aging.

___

Aging is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed CentralWeb of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Click here to subscribe to Aging publication updates.

For media inquiries, please contact [email protected].

EDITORS’ CHOICE: Association of epigenetic age acceleration with MRI biomarkers of aging and Alzheimer’s disease neurodegeneration

Each month, we will highlight a paper published in Aging-US chosen as the “Editors’ Choice.” These selections are handpicked by our editors and accompanied by a brief summary, showcasing research with significant impact and novel insights in aging and age-related diseases.

In the research paper, titled “Association of epigenetic age acceleration with MRI biomarkers of aging and Alzheimer’s disease neurodegeneration,” researchers investigated whether epigenetic clocks of biological aging are associated with MRI markers of brain aging and Alzheimer’s disease-related neurodegeneration in 1,196 older women. While none of the five epigenetic clocks examined were linked to accelerated overall brain aging, one measure—AgeAccelGrim2—was associated with MRI patterns related to neurodegeneration.

The findings suggest this relationship was largely driven by DNA methylation markers linked to smoking history and changes in frontal and temporal brain regions rather than areas typically affected early in Alzheimer’s disease.

Overall, the study indicates that epigenetic aging and brain aging may reflect different aspects of the aging process, while highlighting the potential role of smoking-related biological aging in increasing dementia risk.

Click here to read the full research paper published in Aging-US.

______

To learn more about the journal, please visit www.Aging-US.com​​ and connect with us on social media:

Click here to subscribe to Aging-US publication updates.

For media inquiries, please contact [email protected].

Alpha-Synuclein Overexpression in Rats Reveals Early Clues to Synucleinopathies

“Synucleinopathies are age-dependent neurodegenerative diseases characterized by alpha-synuclein accumulation with distinct vulnerabilities across brain regions.”

Synucleinopathies are a group of age-related neurological disorders, including Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy. Most individuals are not diagnosed until these diseases have significantly progressed, as early symptoms, such as a reduced sense of smell, subtle cognitive or motor changes are too vague to serve as reliable indicators. 

To uncover specific biological signs that appear earlier and clearly point to the disease process, researchers from Saarland University developed a study titled Brain region-specific and systemic transcriptomic alterations in a human alpha-synuclein overexpressing rat model,” featured as the cover of Aging-USVolume 17, Issue 10.

Understanding Synucleinopathies

Synucleinopathies are characterized by the abnormal buildup of the protein alpha-synuclein in the brain. When this protein misfolds, it accumulates inside neurons and forms toxic clumps that disrupt their normal function and threaten cell survival. Because brain samples from patients are usually obtained only after death, scientists rely on animal models to investigate how these diseases start and progress.

The Study:  Exploring Early Gene Changes Associated with Synucleinopathies

A research team from Saarland University, led by Vivien Hoof and Thomas Hentrich, studied a genetically engineered rat model that overexpresses the human form of alpha-synuclein. Their goal was to examine how this protein affects gene activity in both the brain and the gut at different life stages.

The researchers focused on three brain regions known to be involved in movement and cognition: the striatum, cortex, and cerebellum. They examined gene expression in rats at two ages, at five and twelve months, representing early and mid-adulthood, roughly equivalent to young and middle-aged humans. Gut tissue was also studied to better understand the possible systemic effects of alpha-synuclein accumulation.

The Results: Early and Widespread Gene Changes Across the Brain and Gut

The study revealed that gene activity was more significantly disrupted in younger rats, particularly in the striatum, a key area for motor control. Many of the affected genes were involved in communication between nerve cells, suggesting that vital brain functions start shifting early in the disease process.

In older rats, changes were especially noticeable in the cortex and related to myelination, the process that insulates nerve fibers. Similar patterns have also been observed in patients with synucleinopathies, highlighting the value of the rat model.

Importantly, the team identified a core group of genes that were consistently altered across all three brain regions. Some of these same gene changes were also found in the gut, suggesting that the impact of alpha-synuclein accumulation is not limited to the brain but may influence the entire nervous system, including the enteric (gut) nervous system.

The Breakthrough: Evidence That Synucleinopathies May Begin Long Before Symptoms Appear

This study provides compelling evidence that synucleinopathy-related changes begin early at the molecular level, well before clinical symptoms emerge, challenging the notion that such diseases only manifest in later life. These early alterations are both brain region-specific and systemic. The presence of similar gene changes in the gut supports the growing understanding that synucleinopathies are not just brain disorders, but may affect the entire body. These early molecular signals could serve as biomarkers, helping to detect disease before lasting damage occurs.

The Impact: Opening New Paths for Early Detection and Intervention

These findings could shift research toward diagnosing synucleinopathies in their earliest stages. If similar patterns of gene activity can be identified in humans, potentially through blood or stool samples, it may be possible to detect these diseases years before symptoms arise. Early detection could enable timely and more effective treatment.

The study also sheds light on previously overlooked genes involved in neuroprotection and neural communication, which may become new targets for therapeutic development.

Future Perspectives and Conclusion

While synucleinopathies are often seen as diseases of aging, this study highlights that crucial biological changes may occur far earlier. Mapping these early molecular changes provides a strong foundation for developing new diagnostic tools and early-stage treatments. It also reinforces the need to study not just the brain but the entire nervous system, including the gut, which may serve as an accessible window into early disease processes.

Click here to read the full research paper published in Aging-US.

___

Aging is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed CentralWeb of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Click here to subscribe to Aging publication updates.

For media inquiries, please contact [email protected].

  • Follow Us